<DOC>
	<DOCNO>NCT00262639</DOCNO>
	<brief_summary>This placebo control trial ( people receive active people receive inactive medication ) evaluate effectiveness new protocol treat alcohol dependence . Two main medication ( plus ancillary non-placebo control medication ) placebos ( inactive drug ) utilize treat alcohol withdrawal , promote abstinence , reduce drink approximately six-week treatment period . All participant meet criterion Alcohol Dependence drink heavily 72 hour prior receive first study drug . They inject one drug ( flumazenil placebo ) two day period receive second one ( gabapentin placebo ) mouth 39 day . The main hypothesis protocol reduce early alcohol withdrawal symptom reduce relapse drink promote abstinence compare placebo ( inactive ) drug group . Secondary outcome evaluate include reduction craving , improvement sleep , brain activity mood .</brief_summary>
	<brief_title>Prometa Protocol Alcohol Dependence</brief_title>
	<detailed_description>Approximately 60 alcohol dependent individual drink heavily 72 hour , less , prior study participation randomize receive either flumazenil ( intravenously ) two successive day gabapentin ( orally ) 39 day match placebo . They also receive hydroxyzine vitamin . Individuals evaluate alcohol withdrawal , response acoustic startle , cognitive ability , crave , mood , sleep drinking first week . They see weekly 6 week take gabapentin placebo provide Combined Behavioral Intervention Therapy ( counsel ) week , , require . Over period evaluate weekly alcohol consumption , crave , sleep , mood , biological marker alcohol consumption ( percent carbohydrate deficient transferrin gamma-glutamyl transferase ) . Blood obtain week 3 6 general health ( liver , blood count etc . ) screening . After end treatment , subject followed-up 4 week 8 week treatment evaluate alcohol consumption , crave , sleep , mood . Subjects undergo functional magnetic resonance imaging ( MRI ) procedure sometime second third week study medication ass cue induce regional brain activation investigate effect medication brain response alcohol visual cue .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>Flumazenil</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>1 . Age 18 70 . 2 . Participants meet criterion primary DSM IV alcohol dependence , drink least 70 % day last 30 day prior assessment , drink least 5 drink per drinking day . 3 . No 72 hour since last drink alcohol . Rationale : focus symptom occur early alcohol cessation period . 4 . Low CIWAAr group : CIWAAr score less equal 6 ; High CIWAAr group : CIWAAr score great equal 7 less equal 15 . 5 . Able read understand questionnaire inform consent . 6 . Has stable housing past 3 month . 1 . Currently meet DSMIV criterion psychoactive substance dependence disorder except nicotine dependence . 2 . Any psychoactive substance abuse , except marijuana nicotine , within last 30 day evidence subject report urine drug screen . 3 . Meets DSMIV criterion current axis I disorder major depression , panic disorder , obsessivecompulsive disorder , generalize anxiety disorder , posttraumatic stress syndrome , bipolar affective disorder , schizophrenia , psychotic disorder organic mental disorder . The rationale exclude symptom disorder may affect dependent variable complicate interpretation data . 4 . No use benzodiazepines excess three time past two week self report urine drug screen . 5 . Subjects must take zolpidem ( Ambien™ ) , zaleplon ( Sonata™ ) , eszopiclone ( Lunesta™ ) excess three time past two week . 6 . No history delirium tremens alcohol withdrawal seizure . 7 . Has current suicidal ideation plan homicidal ideation . 8 . Need maintenance acute treatment psychoactive medication include antiseizure medication . 9 . Use disulfiram , naltrexone , acamprosate , anticonvulsant last 30 day . 10 . Clinically significant medical problem cardiovascular , renal , GI , endocrine problem would impair participation limit medication ingestion . 11 . Sexually active female childbearing potential pregnant ( beta HCG ) , nursing , use reliable form birth control . 12 . Has current charge pending violent crime ( include DUI related offense ) . 13 . Has take gabapentin flumazenil last month experience adverse effect time past . 14 . Hepatocellular disease indicate elevation SGPT ( ALT ) SGOT ( AST ) great 3 time normal screening . 15 . Persons metal implant pacemaker since fMRI use .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Alcoholism</keyword>
	<keyword>Alcohol Dependence</keyword>
	<keyword>Alcohol Withdrawal</keyword>
	<keyword>Treatment</keyword>
	<keyword>Pharmacotherapy</keyword>
</DOC>